107. LONG-TERM EFFICACY OF SECUKINUMAB CONDITIONAL ON RESPONSE STATUS AT WEEK 12: ANALYSIS IN TUMOUR NECROSIS FACTOR α INHIBITOR–NAÏVE AND TUMOUR NECROSIS FACTOR α INHIBITOR INADEQUATE RESPONDER PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.